|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sarmento-Ribeiro AB, Scorilas A, Gonçalves
AC, Efferth T and Trougakos IP: The emergence of drug resistance to
targeted cancer therapies: Clinical evidence. Drug Resist Updat.
47:1006462019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hall MD, Okabe M, Shen DW, Liang XJ and
Gottesman MM: The role of cellular accumulation in determining
sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol
Toxicol. 48:495–535. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mikamori M, Yamada D, Eguchi H, Hasegawa
S, Kishimoto T, Tomimaru Y, Asaoka T, Noda T, Wada H, Kawamoto K,
et al: MicroRNA-155 controls exosome synthesis and promotes
gemcitabine resistance in pancreatic ductal adenocarcinoma. Sci
Rep. 7:423392017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu T, Chen G, Sun D, Lei M, Li Y, Zhou C,
Li X, Xue W, Wang H, Liu C and Xu J: Exosomes containing miR-21
transfer the characteristic of cisplatin resistance by targeting
PTEN and PDCD4 in oral squamous cell carcinoma. Acta Biochim
Biophys Sin (Shanghai). 49:808–816. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B,
Zhao J, Xia S, Fan S, Yu X, et al: Exosomal transfer of miR-501
confers doxorubicin resistance and tumorigenesis via targeting of
BLID in gastric cancer. Cancer Lett. 459:122–134. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Tong X, Zhou Z, Wang S, Lei Z,
Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al: Circular RNA
hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced
epithelial-mesenchymal transition and metastasis by controlling
TIF1γ in non-small cell lung cancer. Mol Cancer. 17:1402018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu J, Li Y, Tong J, Gao J, Guo Q, Zhang
L, Wang B, Zhao H, Wang H, Jiang E, et al: Long non-coding
RNA-dependent mechanism to regulate heme biosynthesis and
erythrocyte development. Nat Commun. 9:43862018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai Q, Wang S, Jin L, Weng M, Zhou D, Wang
J, Tang Z and Quan Z: Long non-coding RNA GBCDRlnc1 induces
chemoresistance of gallbladder cancer cells by activating
autophagy. Mol Cancer. 18:822019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hong X, Liu N, Liang Y, He Q, Yang X, Lei
Y, Zhang P, Zhao Y, He S, Wang Y, et al: Circular RNA CRIM1
functions as a ceRNA to promote nasopharyngeal carcinoma metastasis
and docetaxel chemoresistance through upregulating FOXQ1. Mol
Cancer. 19:332020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Wang Y, Wang Q, Liu Y, Bao W and Wu
S: Exosomes in cancer: Small transporters with big functions.
Cancer Lett. 435:55–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bandari SK, Purushothaman A, Ramani VC,
Brinkley GJ, Chandrashekar DS, Varambally S, Mobley JA, Zhang Y,
Brown EE, Vlodavsky I and Sanderson RD: Chemotherapy induces
secretion of exosomes loaded with heparanase that degrades
extracellular matrix and impacts tumor and host cell behavior.
Matrix Biol. 65:104–118. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mashouri L, Yousefi H, Aref AR, Ahadi AM,
Molaei F and Alahari SK: Exosomes: Composition, biogenesis, and
mechanisms in cancer metastasis and drug resistance. Mol Cancer.
18:752019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang H, Deng T, Liu R, Ning T, Yang H,
Liu D, Zhang Q, Lin D, Ge S, Bai M, et al: CAF secreted miR-522
suppresses ferroptosis and promotes acquired chemo-resistance in
gastric cancer. Mol Cancer. 19:432020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei LH and Guo JU: Coding functions of
‘noncoding’ RNAs. Science. 367:1074–1075. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bandres E, Bitarte N, Arias F, Agorreta J,
Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ,
et al: microRNA-451 regulates macrophage migration inhibitory
factor production and proliferation of gastrointestinal cancer
cells. Clin Cancer Res. 15:2281–2290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baltruskeviciene E, Schveigert D,
Stankevicius V, Mickys U, Zvirblis T, Bublevic J, Suziedelis K and
Aleknavicius E: Down-regulation of miRNA-148a and miRNA-625-3p in
colorectal cancer is associated with tumor budding. BMC Cancer.
17:6072017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-beta promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Niu Y, Ma F, Huang W, Fang S, Li M, Wei T
and Guo L: Long non-coding RNA TUG1 is involved in cell growth and
chemoresistance of small cell lung cancer by regulating LIMK2b via
EZH2. Mol Cancer. 16:52017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
YiRen H, YingCong Y, Sunwu Y, Keqin L,
Xiaochun T, Senrui C, Ende C, XiZhou L and Yanfan C: Long noncoding
RNA MALAT1 regulates autophagy associated chemoresistance via
miR-23b-3p sequestration in gastric cancer. Mol Cancer. 16:1742017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guarnerio J, Bezzi M, Jeong JC, Paffenholz
SV, Berry K, Naldini MM, Lo-Coco F, Tay Y, Beck AH and Pandolfi PP:
Oncogenic role of fusion-circRNAs derived from cancer-associated
chromosomal translocations. Cell. 166:1055–1056. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao J, Dai C, Yu X, Yin XB and Zhou F:
Circ-TCF4.85 silencing inhibits cancer progression through
microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular
carcinoma. Mol Oncol. 14:447–461. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang YG, Wang T, Ding M, Xiang SH, Shi M
and Zhai B: hsa_circ_0091570 acts as a ceRNA to suppress
hepatocellular cancer progression by sponging hsa-miR-1307. Cancer
Lett. 460:128–138. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Harding C, Heuser J and Stahl P:
Receptor-mediated endocytosis of transferrin and recycling of the
transferrin receptor in rat reticulocytes. J Cell Biol. 97:329–339.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan BT and Johnstone RM: Fate of the
transferrin receptor during maturation of sheep reticulocytes in
vitro: Selective externalization of the receptor. Cell. 33:967–978.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang M, Zhou L, Yu F, Zhang Y, Li P and
Wang K: The functional roles of exosomal long non-coding RNAs in
cancer. Cell Mol Life Sci. 76:2059–2076. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Colombo M, Moita C, van Niel G, Kowal J,
Vigneron J, Benaroch P, Manel N, Moita LF, Théry C and Raposo G:
Analysis of ESCRT functions in exosome biogenesis, composition and
secretion highlights the heterogeneity of extracellular vesicles. J
Cell Sci. 126:5553–5565. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Barile L and Vassalli G: Exosomes: Therapy
delivery tools and biomarkers of diseases. Pharmacol Ther.
174:63–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Khare D, Or R, Resnick I, Barkatz C,
Almogi-Hazan O and Avni B: Mesenchymal stromal cell-derived
exosomes affect mRNA expression and function of B-lymphocytes.
Front Immunol. 9:30532018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Burrello J, Monticone S, Gai C, Gomez Y,
Kholia S and Camussi G: Stem cell-derived extracellular vesicles
and immune-modulation. Front Cell Dev Biol. 4:832016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jayaseelan VP: Emerging role of exosomes
as promising diagnostic tool for cancer. Cancer Gene Ther.
27:395–398. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Meldolesi J: Exosomes and ectosomes in
intercellular communication. Curr Biol. 28:R435–R444. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lakkaraju A and Rodriguez-Boulan E:
Itinerant exosomes: Emerging roles in cell and tissue polarity.
Trends Cell Biol. 18:199–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kahroba H, Hejazi MS and Samadi N:
Exosomes: From carcinogenesis and metastasis to diagnosis and
treatment of gastric cancer. Cell Mol Life Sci. 76:1747–1758. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li Z, Chen Z, Hu G and Jiang Y: Roles of
circular RNA in breast cancer: Present and future. Am J Transl Res.
11:3945–3954. 2019.PubMed/NCBI
|
|
48
|
Zeng A, Wei Z, Yan W, Yin J, Huang X, Zhou
X, Li R, Shen F, Wu W, Wang X and You Y: Exosomal transfer of
miR-151a enhances chemosensitivity to temozolomide in
drug-resistant glioblastoma. Cancer Lett. 436:10–21. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jin G, Liu Y, Zhang J, Bian Z, Yao S, Fei
B, Zhou L, Yin Y and Huang Z: A panel of serum exosomal microRNAs
as predictive markers for chemoresistance in advanced colorectal
cancer. Cancer Chemother Pharmacol. 84:315–325. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qin X, Guo H, Wang X, Zhu X, Yan M, Wang
X, Xu Q, Shi J, Lu E, Chen W and Zhang J: Exosomal miR-196a derived
from cancer-associated fibroblasts confers cisplatin resistance in
head and neck cancer through targeting CDKN1B and ING5. Genome
Biol. 20:122019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yin J, Zeng A, Zhang Z, Shi Z, Yan W and
You Y: Exosomal transfer of miR-1238 contributes to
temozolomide-resistance in glioblastoma. EBioMedicine. 42:238–251.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ji R, Zhang X, Gu H, Ma J, Wen X, Zhou J,
Qian H, Xu W, Qian J and Lin J: miR-374a-5p: A new target for
diagnosis and drug resistance therapy in gastric cancer. Mol Ther
Nucleic Acids. 18:320–331. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang G, Zhao W, Wang H, Qiu G, Jiang Z,
Wei G and Li X: Exosomal MiR-744 inhibits proliferation and
sorafenib chemoresistance in hepatocellular carcinoma by targeting
PAX2. Med Sci Monit. 25:7209–7217. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu Y, Tan J, Ou S, Chen J and Chen L:
Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth
in hepatocellular cancer by targeting the VHL/HIF axis. J Physiol
Biochem. 75:391–401. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ren D, Lin B, Zhang X, Peng Y, Ye Z, Ma Y,
Liang Y, Cao L, Li X, Li R, et al: Maintenance of cancer stemness
by miR-196b-5p contributes to chemoresistance of colorectal cancer
cells via activating STAT3 signaling pathway. Oncotarget.
8:49807–49823. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen WX, Xu LY, Qian Q, He X, Peng WT, Zhu
YL and Cheng L: Analysis of miRNA signature differentially
expressed in exosomes from adriamycin-resistant and parental human
breast cancer cells. Biosci Rep. 38:BSR201810902018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li H and Li F: Exosomes from BM-MSCs
increase the population of CSCs via transfer of miR-142-3p. Br J
Cancer. 119:744–755. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Deng X, Ruan H, Zhang X, Xu X, Zhu Y, Peng
H, Zhang X, Kong F and Guan M: Long noncoding RNA CCAL transferred
from fibroblasts by exosomes promotes chemoresistance of colorectal
cancer cells. Int J Cancer. 146:1700–1716. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kulkarni B, Kirave P, Gondaliya P, Jash K,
Jain A, Tekade RK and Kalia K: Exosomal miRNA in chemoresistance,
immune evasion, metastasis and progression of cancer. Drug Discov
Today. 24:2058–2067. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Au Yeung CL, Co NN, Tsuruga T, Yeung TL,
Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, et al: Exosomal
transfer of stroma-derived miR21 confers paclitaxel resistance in
ovarian cancer cells through targeting APAF1. Nat Commun.
7:111502016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Richards KE, Zeleniak AE, Fishel ML, Wu J,
Littlepage LE and Hill R: Cancer-associated fibroblast exosomes
regulate survival and proliferation of pancreatic cancer cells.
Oncogene. 36:1770–1778. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Nio K, Yamashita T and Kaneko S: The
evolving concept of liver cancer stem cells. Mol Cancer. 16:42017.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Santos JC, Lima NDS, Sarian LO, Matheu A,
Ribeiro ML and Derchain SFM: Exosome-mediated breast cancer
chemoresistance via miR-155 transfer. Sci Rep. 8:8292018.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Shen M, Dong C, Ruan X, Yan W, Cao M,
Pizzo D, Wu X, Yang L, Liu L, Ren X and Wang SE:
Chemotherapy-induced extracellular vesicle miRNAs promote breast
cancer stemness by targeting ONECUT2. Cancer Res. 79:3608–3621.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu T, Zhang X, Du L, Wang Y, Liu X, Tian
H, Wang L, Li P, Zhao Y, Duan W, et al: Exosome-transmitted
miR-128-3p increase chemosensitivity of oxaliplatin-resistant
colorectal cancer. Mol Cancer. 18:432019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang M, Qiu R, Yu S, Xu X, Li G, Gu R, Tan
C, Zhu W and Shen B: Paclitaxel-resistant gastric cancer MGC-803
cells promote epithelial-to-mesenchymal transition and
chemoresistance in paclitaxel-sensitive cells via exosomal delivery
of miR-155-5p. Int J Oncol. 54:326–338. 2019.PubMed/NCBI
|
|
68
|
Ma Y, Yuwen D, Chen J, Zheng B, Gao J, Fan
M, Xue W, Wang Y, Li W, Shu Y, et al: Exosomal transfer of
cisplatin-induced miR-425-3p confers cisplatin resistance In NSCLC
through activating autophagy. Int J Nanomedicine. 14:8121–8132.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Deng Z, Rong Y, Teng Y, Zhuang X,
Samykutty A, Mu J, Zhang L, Cao P, Yan J, Miller D and Zhang HG:
Exosomes miR-126a released from MDSC induced by DOX treatment
promotes lung metastasis. Oncogene. 36:639–651. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhu X, Shen H, Yin X, Yang M, Wei H, Chen
Q, Feng F, Liu Y, Xu W and Li Y: Macrophages derived exosomes
deliver miR-223 to epithelial ovarian cancer cells to elicit a
chemoresistant phenotype. J Exp Clin Cancer Res. 38:812019.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Adamczyk A, Kruczak A, Harazin-Lechowska
A, Ambicka A, Grela-Wojewoda A, Domagała-Haduch M, Janecka-Widła A,
Majchrzyk K, Cichocka A, Ryś J and Niemiec J: Relationship between
HER2 gene status and selected potential biological features related
to trastuzumab resistance and its influence on survival of breast
cancer patients undergoing trastuzumab adjuvant treatment. Onco
Targets Ther. 11:4525–4535. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Han M, Gu Y, Lu P, Li J, Cao H, Li X, Qian
X, Yu C, Yang Y, Yang X, et al: Exosome-mediated lncRNA AFAP1-AS1
promotes trastuzumab resistance through binding with AUF1 and
activating ERBB2 translation. Mol Cancer. 19:262020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zheng Z, Chen M, Xing P, Yan X and Xie B:
Increased expression of exosomal AGAP2-AS1 (AGAP2 antisense RNA 1)
in breast cancer cells inhibits trastuzumab-induced cell
cytotoxicity. Med Sci Monit. 25:2211–2220. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Dong H, Wang W, Chen R, Zhang Y, Zou K, Ye
M, He X, Zhang F and Han J: Exosome-mediated transfer of
lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast
cancer. Int J Oncol. 53:1013–1026. 2018.PubMed/NCBI
|
|
75
|
Wang X, Pei X, Guo G, Qian X, Dou D, Zhang
Z, Xu X and Duan X: Exosome-mediated transfer of long noncoding RNA
H19 induces doxorubicin resistance in breast cancer. J Cell
Physiol. 235:6896–6904. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen
S, Wang Y, Wang T and Hou Y: Carcinoma-associated fibroblasts
promote the stemness and chemoresistance of colorectal cancer by
transferring exosomal lncRNA H19. Theranostics. 8:3932–3948. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ramachandran I, Thavathiru E, Ramalingam
S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A,
Anant S and Queimado L: Wnt inhibitory factor 1 induces apoptosis
and inhibits cervical cancer growth, invasion and angiogenesis in
vivo. Oncogene. 31:2725–2737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Tenbaum SP, Ordóñez-Morán P, Puig I,
Chicote I, Arqués O, Landolfi S, Fernández Y, Herance JR, Gispert
JD, Mendizabal L, et al: β-catenin confers resistance to PI3K and
AKT inhibitors and subverts FOXO3a to promote metastasis in colon
cancer. Nat Med. 18:892–901. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Arend RC, Londoño-Joshi AI, Straughn JM Jr
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wickström M, Dyberg C, Milosevic J, Einvik
C, Calero R, Sveinbjörnsson B, Sandén E, Darabi A, Siesjö P, Kool
M, et al: Wnt/β-catenin pathway regulates MGMT gene expression in
cancer and inhibition of Wnt signalling prevents chemoresistance.
Nat Commun. 6:89042015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Li Z, Jiang P, Li J, Peng M, Zhao X, Zhang
X, Chen K, Zhang Y, Liu H, Gan L, et al: Tumor-derived exosomal
lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in
pancreatic ductal adenocarcinoma. Oncogene. 37:3822–3838. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang J, Lv B, Su Y, Wang X, Bu J and Yao
L: Exosome-mediated transfer of lncRNA HOTTIP promotes cisplatin
resistance in gastric cancer cells by regulating HMGA1/miR-218
axis. Onco Targets Ther. 12:11325–11338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Kang M, Ren M, Li Y, Fu Y, Deng M and Li
C: Exosome-mediated transfer of lncRNA PART1 induces gefitinib
resistance in esophageal squamous cell carcinoma via functioning as
a competing endogenous RNA. J Exp Clin Cancer Res. 37:1712018.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang Z, Yin J, Lu C, Wei Y, Zeng A and
You Y: Exosomal transfer of long non-coding RNA SBF2-AS1 enhances
chemoresistance to temozolomide in glioblastoma. J Exp Clin Cancer
Res. 38:1662019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhang W, Cai X, Yu J, Lu X, Qian Q and
Qian W: Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes
erlotinib resistance in non-small cell lung cancer. Int J Oncol.
53:527–538. 2018.PubMed/NCBI
|
|
86
|
Zhao Z, Ji M, Wang Q, He N and Li Y:
Circular RNA Cdr1as upregulates SCAI to suppress cisplatin
resistance in ovarian cancer via miR-1270 suppression. Mol Ther
Nucleic Acids. 18:24–33. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Hon KW, Ab-Mutalib NS, Abdullah NMA, Jamal
R and Abu N: Extracellular Vesicle-derived circular RNAs confers
chemoresistance in colorectal cancer. Sci Rep. 9:164972019.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wang X, Zhang H, Yang H, Bai M, Ning T,
Deng T, Liu R, Fan Q, Zhu K, Li J, et al: Exosome-delivered circRNA
promotes glycolysis to induce chemoresistance through the
miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 14:539–555.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ding C, Yi X, Wu X, Bu X, Wang D, Wu Z,
Zhang G, Gu J and Kang D: Exosome-mediated transfer of circRNA
CircNFIX enhances temozolomide resistance in glioma. Cancer Lett.
479:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Wang X, Zhang H, Bai M, Ning T, Ge S, Deng
T, Liu R, Zhang L, Ying G and Ba Y: Exosomes serve as nanoparticles
to deliver anti-miR-214 to reverse chemoresistance to cisplatin in
gastric cancer. Mol Ther. 26:774–783. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Jingyue S, Xiao W, Juanmin Z, Wei L,
Daoming L and Hong X: TFAP2E methylation promotes 5-fluorouracil
resistance via exosomal miR-106a-5p and miR-421 in gastric cancer
MGC-803 cells. Mol Med Rep. 20:323–331. 2019.PubMed/NCBI
|
|
92
|
Patel GK, Khan MA, Bhardwaj A, Srivastava
SK, Zubair H, Patton MC, Singh S, Khushman M and Singh AP: Exosomes
confer chemoresistance to pancreatic cancer cells by promoting ROS
detoxification and miR-155-mediated suppression of key
gemcitabine-metabolising enzyme, DCK. Br J Cancer. 116:609–619.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Xu Y and Zhu M: Novel exosomal miR-46146
transfer oxaliplatin chemoresistance in colorectal cancer. Clin
Transl Oncol. 22:1105–1116. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Chen WX, Xu LY, Qian Q, He X, Peng WT, Fan
WQ, Zhu YL, Tang JH and Cheng L: d Rhamnose β-hederin reverses
chemoresistance of breast cancer cells by regulating
exosome-mediated resistance transmission. Biosci Rep.
38:BSR201801102018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kanlikilicer P, Bayraktar R, Denizli M,
Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang
X, et al: Exosomal miRNA confers chemo resistance via targeting
Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine.
38:100–112. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Weiner-Gorzel K, Dempsey E, Milewska M,
McGoldrick A, Toh V, Walsh A, Lindsay S, Gubbins L, Cannon A,
Sharpe D, et al: Overexpression of the microRNA miR-433 promotes
resistance to paclitaxel through the induction of cellular
senescence in ovarian cancer cells. Cancer Med. 4:745–758. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhu L, Zhu Y, Han S, Chen M, Song P, Dai
D, Xu W, Jiang T, Feng L, Shin VY, et al: Impaired autophagic
degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in
gastric cancer. Cell Death Dis. 10:3832019. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Lee JW, Guan W, Han S, Hong DK, Kim LS and
Kim H: MicroRNA-708-3p mediates metastasis and chemoresistance
through inhibition of epithelial-to-mesenchymal transition in
breast cancer. Cancer Sci. 109:1404–1413. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Shen Z, Zhou L, Zhang C and Xu J:
Reduction of circular RNA Foxo3 promotes prostate cancer
progression and chemoresistance to docetaxel. Cancer Lett.
468:88–101. 2020. View Article : Google Scholar : PubMed/NCBI
|
